Issue Date | Title | Author(s) |
2022-07 | Development of an age- and comorbidity adjusted- optimal radiotherapy utilisation rate for women with breast cancer. | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
2023-08-22 | Development of an age- and comorbidity- adjusted optimal radiotherapy utilisation rate for lung, rectal, prostate and cervical cancers. | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
2020-12-01 | Factors affecting radiotherapy utilisation in geriatric oncology patients in NSW, Australia | Mackenzie, P; Vajdic, C; Delaney, G; Gabriel, G; Agar, M; Comans, T; Barton, M |
2023-05 | OC-0755 Radiotherapy Utilisation and Geriatric Oncology: Lung, Rectal, Prostate and Cervical Cancer | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
2022-05-01 | OC-0921 Age- and Comorbidity- Adjusted Optimal Radiotherapy Utilisation Rate for Women with Breast Cancer | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
2022-10-19 | Radiotherapy utilisation rates for patients with cancer as a function of age: A systematic review. | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Morris, L; Agar, M; Gabriel, G; Barton, M |
2022-10-01 | SIOG2022-0007 Development of an Age- and Comorbidity- Adjusted Optimal Radiotherapy Utilisation Rate for Patients with Lung Cancer | Mackenzie, P; Vajdic, C; Delaney, G; Comans, T; Agar, M; Gabriel, G; Barton, M |
2022 | The Medicines Intelligence Centre of Research Excellence: Co-creating real-world evidence to support the evidentiary needs of Australian medicines regulators and payers. | Pratt, N; Camacho, X; Vajdic, C; Degenhardt, L; Laba, T-L; Hillen, J; Etherton-Beer, C; Preen, D; Jorm, L; Donnolley, N; Havard, A; Pearson, S-A |